Abbott India Ltd has informed BSE that the company entered into a fresh distribution agreement with Novo Nordisk India Pvt Ltd for sale and distribution of their Insulin products in India for the period January 1, 2005 to December 31, 2006. The old agreement expired on December 31, 2004.

Abbott India operates in both acute and lifestyle therapies. It is focusing on its core therapeutic areas in pharmaceuticals, namely urology, CNS products, gastroenterology, diabetes care, pain management, specialized anaesthesia range and neonatology.